Curaleaf Holdings (CURLF) Capital Expenditures Growth (1y) (2020 - 2024)
Curaleaf Holdings (CURLF) Capital Expenditures Growth (1y) (2020 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 8.33% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -19.86% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.95% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 73.63% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.19% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -37.60% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | -42.11% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Curaleaf Holdings | 2.49 Bn | 2.39 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 56.37% |
| Sep 30, 2024 | -80.97% |
| Dec 31, 2023 | -79.10% |
| Dec 31, 2022 | 552.45% |
| Jun 30, 2022 | 27.72% |
| Mar 31, 2022 | 4.68% |
| Dec 31, 2021 | -127.79% |
| Sep 30, 2021 | -135.60% |
| Jun 30, 2021 | -45.42% |
| Mar 31, 2021 | -38.52% |
| Dec 31, 2020 | 31.92% |